As of Jun 22
| -0.0024 / -0.92%|
The 2 analysts offering 12-month price forecasts for ImmunoCellular Therapeutics Ltd have a median target of 42.50, with a high estimate of 80.00 and a low estimate of 5.00. The median estimate represents a +15,974.13% increase from the last price of 0.26.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.